ID | Histology | Gender | Age | T stage | N stage | M stage | Clinical stage | Extrathyroidal extension | Recurrence risk stratification |
---|---|---|---|---|---|---|---|---|---|
P01 | PTC | Male | 64 | T1b | N0 | M0 | I | Yes | Low risk |
P02 | PTC | Female | 47 | T1b | N0 | M0 | I | No | Low risk |
P03 | PTC | Female | 49 | T1a | N0 | M0 | I | No | Low risk |
P04 | PTC | Male | 34 | T1b | N1a | M0 | I | No | Intermediate risk |
P05 | PTC | Female | 55 | T1a | N0 | M0 | I | No | Low risk |
P06 | PTC | Female | 46 | T1b | N0 | M0 | I | No | Low risk |
P07 | PTC | Male | 55 | T1a | N0 | M0 | I | No | Low risk |
P08 | PTC | Male | 21 | T1b | N1a | M0 | I | No | Intermediate risk |
P09 | PTC | Male | 53 | T1a | N0 | M0 | I | No | Low risk |
P10 | PTC | Male | 41 | T1b | N1b | M0 | I | No | Intermediate risk |
P11 | PTC | Male | 62 | T1b | N0 | M0 | I | No | Low risk |
P12 | PTC | Female | 59 | T2 | N1 | M0 | II | No | Low risk |
P13 | PTC | Female | 23 | T1b | N0 | M0 | I | No | Low risk |
P14 | PTC | Female | 60 | T1b | N0 | M0 | I | No | Low risk |
P15 | PTC | Female | 55 | T1a | N1a | M0 | II | No | Low risk |
P16 | PTC | Female | 54 | T1a | N0 | M0 | I | No | Low risk |
P17 | PTC | Female | 47 | T1b | N0 | M0 | I | No | Low risk |
P18 | PTC | Female | 40 | T1b | N1a | M0 | I | No | Intermediate risk |
P19 | PTC | Female | 39 | T1b | N1a | M0 | I | No | Intermediate risk |
P20 | PTC | Male | 29 | T1b | N1a | M0 | I | No | Intermediate risk |
P21 | PTC | Female | 50 | T1b | N0 | M0 | I | No | Low risk |
P22 | PTC | Male | 34 | T1b | N1a | M0 | I | No | Intermediate risk |
P23 | PTC | Female | 55 | T1b | N1 | M0 | II | No | Intermediate risk |
P24 | PTC | Female | 52 | T1a | N0 | M0 | I | No | Low risk |
P25 | PTC | Female | 54 | T2 | N0 | M0 | I | Yes | Low risk |
P26 | PTC | Female | 25 | T1a | N1a | M0 | I | No | Intermediate risk |
P27 | PTC | Female | 49 | T1a | N0 | M0 | I | No | Low risk |
P28 | PTC | Female | 47 | T1a | N1a | M0 | I | No | Intermediate risk |
P29 | PTC | Female | 38 | T1b | N1b | M0 | I | Yes | Intermediate risk |
P30 | PTC | Female | 33 | T1b | N0 | M0 | I | No | Low risk |